What is the "With Ipamorelin" protocol for CJC-1295?

100 mcg + 200-300 mcg Ipamorelin · 2-3× daily · 8-12 weeks

Dosing

CJC-1295 (no DAC) - dosing protocol

CJC-1295 (no DAC) is dosed at 100 mcg under the skin (s.c. injection) 2-3× daily alongside a GHRP (growth-hormone-releasing peptide) like Ipamorelin. Short half-life (~30 min) mimics natural pulsatility. DAC version is dosed 1-2× weekly.

Route

Subcutaneous (s.c.)

Dose

100 mcg / administration

Half-life

~30 min (no DAC); 6-8 days (with DAC)

Storage

-20°C lyophilized; reconstituted — 21 days at 2-8°C

Dosing regimens

Standard regimens from the literature. The choice depends on what you're trying to achieve.

Protocol

With Ipamorelin

Dose: 100 mcg + 200-300 mcg Ipamorelin
Frequency: 2-3× daily
Duration: 8-12 weeks

Side effects

CJC-1295 (no DAC) has a favorable profile because it preserves physiological pulsatility. Most common are injection-site reactions, transient flushing, and mild hunger. The DAC version has a similar profile but with more sustained water retention due to the constant GHRH signal.

See full side-effect list

Encyclopedia

Full scientific profile for CJC-1295

Calculator

What does this protocol cost per day?

Last reviewed: 6 May 2026by PeptidLabs Editorial